Well vaccines as a field is super-mega broad, there are so many pure research sub-disciplines one can choose to be an expert on due to the intersection of medicine/immunology/chemistry/biology. And even those are super broad themselves. From an applied sciences standpoint again there are various disciplines depending on the particular vaccine technology - fermentation, protein purification, conjugation chemistry, formulation, drug delivery, etc, etc, etc. From an analytical chemistry/biology standpoint there are dozens more fields that come into the picture when testing. You can spend years and decades in any of these niche fields and still not probe the depths of our accumulated knowledge. And once you have a product, you get into the regulatory domain - finding the quickest and shortest path to the market - which is its own nightmare.
I don't know much about the particulars of the vaccine you are referring to, but when it comes to investing, I think it is always safe to assume that all major investing firms have ready access to SMEs that can give them the scoop on any company they're interested in.
I don't know much about the particulars of the vaccine you are referring to, but when it comes to investing, I think it is always safe to assume that all major investing firms have ready access to SMEs that can give them the scoop on any company they're interested in.